Single-Dose CRISPR/Cas9 Therapy Extends Lifespan of Mice with Hutchinson-Gilford Progeria Syndrome
Ontology highlight
ABSTRACT: Single-Dose CRISPR/Cas9 Therapy Extends Lifespan of Mice with Hutchinson-Gilford Progeria Syndrome
PROVIDER: PRJNA506719 | ENA |
REPOSITORIES: ENA
ACCESS DATA